AKTS – Akoustis Technologies Inc
Float Short %
0.71
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.04
EPS Last/This Y
1.44
EPS This/Next Y
0.25
Price
0.04
Target Price
31.67
Analyst Recom
1
Performance Q
Upside
N/A
Beta
Ticker: AKTS
19 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | AKTS | 21.65 | N/A | N/A | 0 |
| 2026-01-26 | AKTS | 21.64 | N/A | N/A | 0 |
| 2026-01-27 | AKTS | 21.13 | N/A | N/A | 0 |
| 2026-01-28 | AKTS | 20.47 | N/A | N/A | 0 |
| 2026-01-29 | AKTS | 19.64 | N/A | N/A | 0 |
| 2026-01-30 | AKTS | 20.18 | N/A | N/A | 0 |
| 2026-02-02 | AKTS | 21.96 | N/A | N/A | 0 |
| 2026-02-03 | AKTS | 20.82 | N/A | N/A | 0 |
| 2026-02-04 | AKTS | 19.89 | N/A | N/A | 0 |
| 2026-02-05 | AKTS | 19.52 | N/A | N/A | 0 |
| 2026-02-06 | AKTS | 18.91 | N/A | N/A | 0 |
| 2026-02-09 | AKTS | 18.98 | N/A | N/A | 0 |
| 2026-02-10 | AKTS | 17.86 | N/A | N/A | 0 |
| 2026-02-11 | AKTS | 18.08 | N/A | N/A | 0 |
| 2026-02-12 | AKTS | 17.93 | N/A | N/A | 0 |
| 2026-02-13 | AKTS | 17.77 | N/A | N/A | 0 |
| 2026-02-17 | AKTS | 17.91 | N/A | N/A | 0 |
| 2026-02-18 | AKTS | 17.73 | N/A | N/A | 0 |
| 2026-02-20 | AKTS | 18.9 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
No data found
19 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | AKTS | 18.49 | 5.54 | 0 |
| 2026-01-26 | AKTS | 18.49 | 5.54 | 0 |
| 2026-01-27 | AKTS | 18.49 | 5.54 | 0 |
| 2026-01-28 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-01-29 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-01-30 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-02 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-03 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-04 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-05 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-06 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-10 | AKTS | 34.85 | 5.54 | 0.17 |
| 2026-02-11 | AKTS | 34.85 | 5.54 | 0.70 |
| 2026-02-12 | AKTS | 34.17 | 5.54 | 0.71 |
| 2026-02-13 | AKTS | 34.17 | 5.54 | 0.71 |
| 2026-02-17 | AKTS | 34.17 | 5.54 | 0.71 |
| 2026-02-18 | AKTS | 34.17 | 5.54 | 0.71 |
| 2026-02-19 | AKTS | 34.17 | 5.54 | 0.71 |
| 2026-02-20 | AKTS | 34.17 | 5.54 | 0.71 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.04
Avg. EPS Est. Current Quarter
-0.07
Avg. EPS Est. Next Quarter
-0.07
Insider Transactions
34.17
Institutional Transactions
5.54
Beta
Average Sales Estimate Current Quarter
9
Average Sales Estimate Next Quarter
10
Fair Value
Quality Score
54
Growth Score
48
Sentiment Score
13
Actual DrawDown %
99.8
Max Drawdown 5-Year %
-99.8
Target Price
31.67
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
Average EPS Est. Cur. Y
-0.45
EPS Next Y. (Est.)
-0.2
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.64
Return on Equity vs Sector %
183.5
Return on Equity vs Industry %
216.6
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.09
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees:
Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts.
stock quote shares AKTS – Akoustis Technologies Inc Stock Price stock today
news today AKTS – Akoustis Technologies Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch AKTS – Akoustis Technologies Inc yahoo finance google finance
stock history AKTS – Akoustis Technologies Inc invest stock market
stock prices AKTS premarket after hours
ticker AKTS fair value insiders trading